1. Treatment of advanced prostatic cancer with LHRH-analogue ICI 118630: clinical response and hormonal mechanisms;Ahmed, SR, Brooman; PJC, Shalet; SM, Howell; A, Blacklock; N.J.;Lancet,1983
2. Advanced carcinoma of the prostate: treatment with gonadotrophin releasing hormone agonist;Allen, J.M.; O'Shea, J.P.; Mashiter, K.; Williams, G.R.; Bloom, SR;Br Med y,1983
3. Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer;Waxman, J.H.; Wass, J.A.H.; W'F, Hendry;Br Med Y,1983
4. Therapeutic potential of the LH-RH agonist Zoladex (ICI 118630) in the treatment of advanced breast cancer in preand postmenopausal women. Abstracts of satellite symposium of the 7th international congress of endocrinology;Walker, K.J.; Nicholson, R.I.; Turkes, A.; Plowman, N.; Blamey, R.;7 Steroid Biochem,1984
5. Therapy of precocious puberty: LHRH analogue effects on pubertal growth and maturation. Abstracts of satellite symposium of the 7th international congress of endocrinology. Y7 Steroid Biochem;Comite, F.; Pescovitz, O.H.; Hench, K.; McNemar, A.; Loriaux, D.L.; GB, Jr, Cutler,1984